Literature DB >> 21618615

Effect of fenoterol stereochemistry on the β2 adrenergic receptor system: ligand-directed chiral recognition.

Krzysztof Jozwiak1, Anita Plazinska, Lawrence Toll, Lucita Jimenez, Anthony Yiu-Ho Woo, Rui-Ping Xiao, Irving W Wainer.   

Abstract

The β(2) adrenergic receptor (β(2)-AR) is a model system for studying the ligand recognition process in G protein-coupled receptors. Fenoterol (FEN) is a β(2)-AR selective agonist that has two centers of chirality and exists as four stereoisomers. Radioligand binding studies determined that stereochemistry greatly influences the binding affinity. Subsequent Van't Hoff analysis shows very different thermodynamics of binding depending on the stereoconfiguration of the molecule. The binding of (S,x')-isomers is almost entirely enthalpy controlled whereas binding of (R,x')-isomers is purely entropy driven. Stereochemistry of FEN molecule also affects the coupling of the receptor to different G proteins. In a rat cardiomyocyte contractility model, (R,R')-FEN was shown to selectively activate G(s) protein signaling while the (S,R')-isomer activated both G(i) and G(s) protein. The overall data demonstrate that the chirality at the two chiral centers of the FEN molecule influences the magnitude of binding affinity, thermodynamics of local interactions within the binding site, and the global mechanism of β(2)-AR activation. Differences in thermodynamic parameters and nonuniform G-protein coupling suggest a mechanism of chiral recognition in which observed enantioselectivities arise from the interaction of the (R,x')-FEN stereoisomers with a different receptor conformation than the one with which the (S,x')-isomer interacts.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Keywords:  G-protein Coupled Receptors; Van’t Hoff analysis; affinity; efficacy; stereoselective binding; β2 adrenergic agonists

Mesh:

Substances:

Year:  2011        PMID: 21618615      PMCID: PMC3164500          DOI: 10.1002/chir.20963

Source DB:  PubMed          Journal:  Chirality        ISSN: 0899-0042            Impact factor:   2.437


  22 in total

1.  A new model for protein stereospecificity.

Authors:  A D Mesecar; D E Koshland
Journal:  Nature       Date:  2000-02-10       Impact factor: 49.962

2.  Identification and quantification of beta-adrenoceptors sites in red blood cells from rats.

Authors:  G Kaiser; G Wiemer; G Kremer; J Dietz; D Palm
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-10       Impact factor: 3.000

3.  {Beta}2-adrenergic receptor agonists inhibit the proliferation of 1321N1 astrocytoma cells.

Authors:  L Toll; L Jimenez; N Waleh; K Jozwiak; A Y-H Woo; R-P Xiao; M Bernier; I W Wainer
Journal:  J Pharmacol Exp Ther       Date:  2010-11-11       Impact factor: 4.030

Review 4.  G protein coupled receptor structure and activation.

Authors:  Brian K Kobilka
Journal:  Biochim Biophys Acta       Date:  2006-11-15

5.  Enantioselective separation and online affinity chromatographic characterization of R,R- and S,S-fenoterol.

Authors:  Farideh Beigi; Carlo Bertucci; Weizhong Zhu; Khalid Chakir; Irving W Wainer; Rui-Ping Xiao; Darrell R Abernethy
Journal:  Chirality       Date:  2006-11       Impact factor: 2.437

6.  Separation of drug stereoisomers by the formation of beta-cyclodextrin inclusion complexes.

Authors:  D W Armstrong; T J Ward; R D Armstrong; T E Beesley
Journal:  Science       Date:  1986-05-30       Impact factor: 47.728

7.  Functional coupling of the beta 2-adrenoceptor to a pertussis toxin-sensitive G protein in cardiac myocytes.

Authors:  R P Xiao; X Ji; E G Lakatta
Journal:  Mol Pharmacol       Date:  1995-02       Impact factor: 4.436

8.  The discovery of long acting beta2-adrenoreceptor agonists.

Authors:  Alan D Brown; Mark E Bunnage; Paul A Glossop; Kim James; Rhys Jones; Charlotte A L Lane; Russell A Lewthwaite; Simon Mantell; Christelle Perros-Huguet; David A Price; Mike Trevethick; Rob Webster
Journal:  Bioorg Med Chem Lett       Date:  2007-04-29       Impact factor: 2.823

9.  Involvement of Asn-293 in stereospecific agonist recognition and in activation of the beta 2-adrenergic receptor.

Authors:  K Wieland; H M Zuurmond; C Krasel; A P Ijzerman; M J Lohse
Journal:  Proc Natl Acad Sci U S A       Date:  1996-08-20       Impact factor: 11.205

10.  Comparative molecular field analysis of the binding of the stereoisomers of fenoterol and fenoterol derivatives to the beta2 adrenergic receptor.

Authors:  Krzysztof Jozwiak; Chakir Khalid; Mary J Tanga; Ilona Berzetei-Gurske; Lucita Jimenez; Joseph A Kozocas; Anthony Woo; Weizhong Zhu; Rui-Ping Xiao; Darrell R Abernethy; Irving W Wainer
Journal:  J Med Chem       Date:  2007-05-17       Impact factor: 7.446

View more
  2 in total

1.  Interaction of fenoterol stereoisomers with β2-adrenoceptor-G sα fusion proteins: antagonist and agonist competition binding.

Authors:  Michael T Reinartz; Solveig Kälble; Irving W Wainer; Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-01-31       Impact factor: 3.000

2.  Molecular interactions between fenoterol stereoisomers and derivatives and the β₂-adrenergic receptor binding site studied by docking and molecular dynamics simulations.

Authors:  Anita Plazinska; Michal Kolinski; Irving W Wainer; Krzysztof Jozwiak
Journal:  J Mol Model       Date:  2013-09-17       Impact factor: 1.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.